Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice

Abstract excerpt

The prevalence of non-alcoholic fatty liver disease (NAFLD) is constantly increasing, and altered expression of microRNAs (miRNAs) fosters the development and progression of many pathologies, including NAFLD. Therefore, we explored the role of new miRNAs involved in the molecular mechanisms that trigger NAFLD progression and evaluated them as biomarkers for diagnosis. As a NAFLD model, we used apolipoprotein...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Circular RNAs in diseases
• Share to Liver Disease Diagnosis and Treatment
• Share to MicroRNA in disease regulation